Dr. Jon Pritchett hired as VP, QA/RA for Revelation Pharma Corporation

Revelation Pharma Corporation hires
Dr. Jon Pritchett as the Vice President of Quality Assurance and Regulatory Affairs

TAMPA, Fla., (DATE) Osceola Capital (“Osceola”), a lower middle-market private-equity firm, announced today Dr. Jon Pritchett PharmD., RPh., BCSCP has been appointed as the company’s Vice President of Quality Assurance and Regulatory Affairs.

Dr. Pritchett will join the company’s executive team as the Vice President of Quality Assurance and Regulatory Affairs (VP, QA/RA), where his professional expertise and skills will enable him to act as the executive team’s subject matter expert and advise in areas such as quality, compliance, and regulations for 503A and 503B pharmacies. He will focus on product quality assurance as well as development of a culture that embraces industry best-practices throughout the network.

“I could not be more excited to join this team,” said Jon Pritchett, VP, QA/RA. “I’m a practitioner at heart, and I believe that the vision of Revelation Pharma Corporation represents a dramatic leap forward in our ability to connect patients and prescribers with high-quality customized medication solutions.”

“We are excited to have Jon join our executive team,” said Richard Case, CEO of Revelation Pharma. “Jon’s extensive expertise in developing a robust quality affairs program for compounding helps Revelation achieve its vision in elevating the practice of pharmacy amongst its pharmacy network.”

About Dr. Jon Pritchett

Dr. Pritchett joins Revelation Pharma with over 20 years of pharmacy experience, including previously serving as the Pharmacy Program Director at Accreditation Commission for Health Care (ACHC), where among other roles he oversaw compounding accreditation through the Pharmacy Compounding Accreditation Board (PCAB) and compounding regulatory inspections through ACHC Inspection Services (AIS). Dr. Pritchett is a frequent speaker to professional organizations, regulatory agencies, and pharmacy students on matters concerning USP compounding standard implementation and compliance and is an active member of many professional organizations including the Alliance for Pharmacy Compounding and the American Pharmacists Association.

About Osceola Capital Management

Osceola Capital is a Tampa-based private-equity firm that invests in lower middle-market services companies, typically with EBITDA of $2 million to $10 million. Osceola has extensive experience partnering with management teams to execute buy-and-build strategies and drive long-term value creation. The Revelation Strategy Team includes Ben Moe, and Patrick Watkins. To learn more, visit www.osceola.com.

About Revelation Pharma Corporation

Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing innovative and quality pharmaceutical products and services through “industry best” patient care and solutions for customers. Compounding pharmacy will drastically change in the next five years. Revelation’s belief is that compounding pharmacies will need help and support to adjust to these changes in order to continue to serve the needs of the patient and their healthcare provider.

Contact Shawn Hodges, PharmD
Chief Business Development Officer
shodges@revcustomrx.com

Change the future of compounding pharmacy with us

If you have any specific questions about what an exit/partnership opportunity looks like with Revelation, please contact partnerwithus@revpharmacorp.com

Tel : 1-855-434-6654